Assuntos
Bursite/induzido quimicamente , Infecções por HIV/tratamento farmacológico , Hepatite C/tratamento farmacológico , Inibidores de Proteases/efeitos adversos , Bursite/enzimologia , Bursite/microbiologia , Infecções por HIV/complicações , Infecções por HIV/enzimologia , Infecções por HIV/virologia , Hepatite C/complicações , Hepatite C/enzimologia , Hepatite C/virologia , Humanos , Masculino , Pessoa de Meia-Idade , Inibidores de Proteases/uso terapêuticoRESUMO
Matrix metalloproteinase-19 (MMP-19), originally isolated as an autoantigen from the synovium of a patient suffering from rheumatoid arthritis (RA), is expressed in smooth muscle cells of the tunica media of large blood vessels of an RA patient, but not in the endothelial cell layer. By contrast, in acutely inflamed tissue, synovial capillaries strongly express MMP-19 in the cytoplasm, as shown by immunofluorescence of cryostat sections. In MMP-19-producing capillaries the beta3 integrin chain was found at the endothelial cell surface, as was the vascular endothelial cell growth factor receptor-2 (KDR). The specific tissue inhibitor of metalloproteinases TIMP-1 was absent or faintly stained in MMP-19-expressing capillaries, whereas TIMP-1, but not TIMP-2, was strongly expressed in large vessels and in MMP-19-negative capillaries of RA synovia. In the spontaneously transformed human umbilical vein endothelial cell line ECV304 neither MMP-19 transcripts nor protein could be detected. By contrast, primary cultures of human endothelial cells of either dermal or adipose tissue origin produced MMP-19 mRNA and protein. The results strongly suggest the regulated induction of matrix metalloproteinase-19 in capillary endothelial cells during acute inflammation and hint at a role of MMP-19 in angiogenesis.